Full notification file
General informationNotification NumberB/BE/04/BV1Member State to which the notification was sentBelgiumDate of acknowledgement from the Member State Competent Authority08/09/2004Title of the ProjectEvaluation of the safety of a Feline Herpes
virus, bivalent gene deleted live vaccine, administered as intranasal vaccination to catsProposed period of release:01/07/2004 to 01/07/2008Name of the Institute(s) or Company(ies)Pfizer Animal Health, Pfizer Animal Health
Veterinary Medicine R&D, ipc 821
Ramsgate Road
Sandwich, Kent CT13 9NJ, UK;
3. Is the same GMO release planned elsewhere in the Community?Yes: Ireland; Netherlands; Has the same GMPt been notified elsewhere by the same notifier?YesIf yes, notification number(s): GMO characterizationGMO is a:DNA VirusIdentity of the GMO:The insert originates from a RNA virus.
Feline Herpes virus Type 1Information relating to the recipient or parental organisms from wich the GMO is derived| Common Name | Genus | Species | Subspecies | Strain | Pathovar | | Feline Herpes Virus | Herpesviridae | Alphaherpesvirnae | | | |
|
European Commission administrative informationConsent given by the Member State Competent Authority:Not known